Ankylosing Spondylitis
📧 Sign up to get email alerts when something new happens for Ankylosing Spondylitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-29Clinical Trial Update: A Study Investigating an Exercise and Education Programme for Individuals With Ankylosing Spondylitis [Phase 3]
A Phase 3 study evaluating an exercise and education programme for individuals with ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-16Clinical Trial Update: Study Investigating Enbrel Treatment for Ankylosing Spondylitis
The clinical trial evaluating Enbrel (etanercept) for ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain [Phase 4]
A Phase 4 clinical trial evaluating etanercept in subjects with ankylosing spondylitis in Spain has completed; results posted in 2009.
-
CLINICAL_TRIALS trial_result · 2009-07-29Clinical Trial Update: Study of Intra-articular Delivery of tgAAC94 in Inflammatory Arthritis Subjects [Phase 1, Phase 2]
This update reports the completion of Phase 1 and Phase 2 trials evaluating intra-articular delivery of tgAAC94 for inflammatory arthritis, …
-
CLINICAL_TRIALS trial_result · 2009-07-13Clinical Trial Update: A Study of the Safety and Efficacy of Golimumab in Subjects With Active Ankylosing Spondylitis [Phase 3]
Phase 3 trial evaluating safety and efficacy of golimumab in active ankylosing spondylitis has completed, with results posted in 2009. The t…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-04-29Clinical Trial Update: Clinical Study of Tripterygium Capsule to Treat Early Ankylosing Spondylitis [Phase 2, Phase 3]
Clinical trial update evaluating Tripterygium Capsule for early ankylosing spondylitis in Phase 2 and Phase 3, sponsored by Sun Yat-sen Univ…
-
CLINICAL_TRIALS trial_result · 2008-08-18Clinical Trial Update: Evaluation of a Patient Education Program for Ankylosing Spondylitis [NA]
A completed clinical trial evaluating a patient education program for individuals with ankylosing spondylitis and spondyloarthritis.
-
CLINICAL_TRIALS trial_result · 2008-06-03Clinical Trial Update: Examination of Radiographic Progression, Efficacy and Safety of Long-Term Treatment With Infliximab in Patients With Ankylosing Spondylitis [NA]
This ClinicalTrials.gov update reports on the long-term use of infliximab in ankylosing spondylitis, examining radiographic progression, eff…
-
CLINICAL_TRIALS trial_result · 2008-04-22Clinical Trial Update: Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers. [Phase 3]
A completed Phase 3 trial compared PN 200 with naproxen to evaluate the incidence of gastric ulcers in subjects at risk for NSAID-associated…
-
CLINICAL_TRIALS trial_result · 2008-04-10Clinical Trial Update: Safety and Efficacy of Celecoxib Versus Diclofenac in the Treatment of Ankylosing Spondylitis [Phase 3]
Phase 3 trial comparing celecoxib to diclofenac in ankylosing spondylitis has completed, evaluating comparative safety and efficacy.
-
CLINICAL_TRIALS trial_result · 2008-03-13Clinical Trial Update: Study Evaluating Etanercept in Patients With Ankylosing Spondylitis [Phase 4]
Wyeth (now a Pfizer subsidiary) sponsored a Phase 4 trial evaluating etanercept in Ankylosing Spondylitis. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2008-02-26Clinical Trial Update: Pilot Open Label Clinical Trial With Abatacept in Ankylosing Spondylitis [Phase 2]
This document reports on a pilot open-label Phase 2 clinical trial evaluating abatacept in patients with ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2007-12-13Clinical Trial Update: Study Evaluating Etanercept in the Treatment of Subjects With Ankylosing Spondylitis [Phase 3]
Wyeth (now Pfizer) completed a Phase 3 trial evaluating etanercept for ankylosing spondylitis.
-
CLINICAL_TRIALS trial_result · 2007-12-10Clinical Trial Update: Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis
A completed clinical trial evaluating etanercept (Enbrel) in patients with Ankylosing Spondylitis; sponsor Wyeth is now a subsidiary of Pfiz…
-
CLINICAL_TRIALS trial_result · 2007-12-07Clinical Trial Update: An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis [Phase 4]
This is an open-label, multicenter long-term extension study of etanercept in ankylosing spondylitis (Phase 4), which has completed.
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: An Open-Label Study to Evaluate the Response to Adalimumab in Patients With Active Ankylosing Spondylitis Who Have Failed Standard Therapy or TNF-Alpha Inhibitors (RHAPSODY) [Phase 3]
Completed Phase 3 open-label trial evaluating the response to adalimumab in active ankylosing spondylitis patients who have failed standard …
-
CLINICAL_TRIALS trial_result · 2007-04-10Clinical Trial Update: TNFalfa Blocking Treatment of Spondylarthropathies [Phase 4]
Phase 4 clinical trial evaluating TNF-alpha blockade for spondyloarthropathies has completed, including ankylosing spondylitis and psoriatic…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: Study of Two Schedules of Infliximab Maintenance Therapy in Ankylosing Spondylitis [Phase 3]
A Phase 3 trial update reports two schedules of infliximab maintenance therapy in Ankylosing Spondylitis; the study status is completed.
-
CLINICAL_TRIALS trial_result · 2007-01-15Clinical Trial Update: An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis [Phase 3]
An open-label, multicenter long-term extension study evaluating etanercept in ankylosing spondylitis to assess long-term safety and efficacy…
-
CLINICAL_TRIALS trial_result · 2007-01-15Clinical Trial Update: Study Evaluating Etanercept Treatment of Patients With Ankylosing Spondylitis [Phase 3]
A Phase 3 study evaluating etanercept for ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-05Clinical Trial Update: Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis [Phase 3]
A Phase 3 trial comparing etanercept 50 mg once weekly to 25 mg twice weekly in ankylosing spondylitis has completed.
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Prednisolone in Active Ankylosing Spondylitis (AS) [Phase 2, Phase 3]
A clinical trial update investigates prednisolone for active ankylosing spondylitis in Phase 2 and Phase 3; the current status of the trial …